Repare Therapeutics Inc. (RPTX) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 634 transactions totaling $233.0M, demonstrating a bullish sentiment with $1.4M in net insider flow. The most recent transaction on Jan 28, 2026 involved a transaction of 7,500 shares valued at $0.
No significant insider buying has been recorded for RPTX in the recent period.
No significant insider selling has been recorded for RPTX in the recent period.
Based on recent SEC filings, insider sentiment for RPTX is bullish with an Insider Alignment Score of 50/100 and a net flow of $1.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Repare Therapeutics Inc. (RPTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading RPTX stock, having executed 634 transactions in the past 90 days. The most active insider is Ansbert Gadicke (Executive), who has made 55 transactions totaling $55.7M.
Get notified when executives and directors at RPTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | Civik Thomas | Executive | Disposition | 7,500 | $N/A | $0 | |
| Jan 28, 2026 | D. Rhoads Ann | Executive | Disposition | 4,000 | $N/A | $0 | |
| Jan 28, 2026 | Schafer Carol | Executive | Disposition | 37,941 | $N/A | $0 | |
| Jan 28, 2026 | Schafer Carol | Executive | Disposition | 8,000 | $N/A | $0 | |
| Apr 1, 2024 | Koehler Maria | Executive | Sale | 300 | $4.66 | $1.4K | 10b5-1 |
| Apr 1, 2024 | Zinda Michael | Executive | Sale | 410 | $4.66 | $1.9K | 10b5-1 |
| Apr 1, 2024 | Forte Steve | Executive | Sale | 789 | $4.61 | $3.6K | 10b5-1 |
| Apr 1, 2024 | Mitchell Segal Lloyd | Executive | Sale | 2,491 | $4.63 | $11.5K | 10b5-1 |
| Mar 28, 2024 | Koehler Maria | Executive | Sale | 500 | $4.64 | $2.3K | 10b5-1 |
| Mar 28, 2024 | Zinda Michael | Executive | Sale | 450 | $4.64 | $2.1K | 10b5-1 |
| Mar 28, 2024 | Forte Steve | Executive | Sale | 825 | $4.62 | $3.8K | 10b5-1 |
| Mar 28, 2024 | Mitchell Segal Lloyd | Executive | Sale | 2,650 | $4.62 | $12.2K | 10b5-1 |
| Mar 27, 2024 | Mitchell Segal Lloyd | Executive | Sale | 2,650 | $4.63 | $12.3K | 10b5-1 |
| Mar 27, 2024 | Koehler Maria | Executive | Sale | 500 | $4.62 | $2.3K | 10b5-1 |
| Mar 27, 2024 | Zinda Michael | Executive | Sale | 450 | $4.62 | $2.1K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 46 | $117.2M | 50.2% |
Sale(S) | 228 | $115.8M | 49.6% |
Exercise(M) | 22 | $643.6K | 0.3% |
Disposition(D) | 4 | $0 | 0.0% |
Award(A) | 8 | $0 | 0.0% |
Other(J) | 284 | $0 | 0.0% |
Conversion(C) | 42 | $0 | 0.0% |
Insider activity at Repare Therapeutics Inc. shows mixed signals across all time. While $117.2M in purchases indicates some executive confidence,$115.8M in sales balances the picture, resulting in a modest net flow of $1.4M.31 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Ansbert Gadicke, has transacted $55.7M during this period.